Wang J.S.Sommerhalder, DavidDavidSommerhalderSharma, ManishManishSharmaEdenfield, William JefferyWilliam JefferyEdenfieldSehgal, KartikKartikSehgalOh, Do-YounDo-YounOhJiang, YixingYixingJiangMichalski, JoelJoelMichalskiLee, JeeyunJeeyunLeeHammers, Hans J.Hans J.HammersBai, Li-YuanLi-YuanBaiCHIH-HUNG HSUDampier, Brenda A. P.Brenda A. P.DampierZhou, KefeiKefeiZhouBlum, Lisa K.Lisa K.BlumLancaster, Joanne SloanJoanne SloanLancasterAbhyankar, Dhiraj J.Dhiraj J.AbhyankarLieu, Hsiao D.Hsiao D.LieuHanes, VladimirVladimirHanesNaing, AungAungNaing2026-01-222026-01-222024-01-010732183Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/735537falsePhase 1/2 study of NGM707, an ILT2/ILT4 dual antagonist antibody, in advanced solid tumors: Interim results from dose-escalation.text::journal::journal article2-s2.0-105024233127